Author

M. R. Buchanan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

C. G. Harris· 2 shared I. A. Cadena· 2 shared K. C. Fogg· 2 shared M. A. Jenne· 2 shared W. E. Rochefort· 2 shared A. Almer· 1 shared B. E. Givens· 1 shared B. Keefe· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

C. G. Harris

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Engineering a three-dimensional multilayer multicellular model of endometrial cancer for high throughput drug screening and novel treatment methods

I. A. Cadena, C. Rowlands, M. R. Buchanan, M. A. Jenne, B. Keefe, A. Almer, N. Obasi, C. G. Harris, W. E. Rochefort, B. E. Givens, K. C. Fogg

This paper develops a 3D multilayer multicellular hydrogel model of endometrial cancer for drug screening and treatment development, showing improved microvessel formation and cancer invasion compared to Matrigel.

bioRxiv · Feb 20, 2024 · PreprintBioengineering

Engineering High Throughput Screening Platforms of Cervical Cancer

I. A. Cadena, M. R. Buchanan, C. G. Harris, M. A. Jenne, W. E. Rochefort, D. Nelson, K. C. Fogg

This paper develops a multicellular 3D platform for cervical cancer that integrates with high throughput drug screening to assess anti-metastatic and anti-angiogenic drug efficacy.

bioRxiv · Oct 16, 2022Bioengineering